CAR T-cell Therapies Deemed Cost-effective for B-cell Cancers in New Report – Lymphoma News Today
Lymphoma News Today |
CAR T-cell Therapies Deemed Cost-effective for B-cell Cancers in New Report
Lymphoma News Today In this study, a panel of experts focused on the economic implications of CAR T-cell therapy for the treatment of B-cell malignant cancers. CAR-T therapy involves the genetic engineering of a patient's own T- cells to target proteins that are present … |
